A Study of Safety of PBCLN-003 Following Antibiotic Therapy in Subjects With C.Difficile-associated Diarrhea

NCT03793686 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

26

Enrollment

INDUSTRY

Sponsor class

Stopped Unable to enroll subjects

Conditions

Clostridium Difficile Diarrhea

Interventions

DRUG: PBCLN-003
DRUG: Placebo

Sponsor

Prolacta Bioscience